Navigation Links
Boston Scientific Begins Clinical Trial for Next-Generation Nitinol Stent to Treat Iliac Artery Disease
Date:5/20/2009

NATICK, Mass., May 20 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced the start of patient enrollment in the ORION clinical trial, which is designed to evaluate the Company's EPIC(TM) Self-Expanding Nitinol Stent System for the treatment of iliac artery disease, a form of peripheral artery disease that impacts a patient's lower extremities. The first U.S. patient was enrolled on May 14 by Nicolas W. Shammas, M.D., at Trinity Terrace Park Hospital in Bettendorf, Iowa.

"Peripheral stenting has become a recognized standard in the treatment of iliac arterial disease," said Daniel Clair, M.D., FACS, Principal Investigator of the trial and Chairman of the Department of Vascular Surgery, The Cleveland Clinic Foundation. "The ORION clinical trial will provide important data on the performance of the EPIC Stent in the treatment of atherosclerotic lesions in iliac arteries."

"We are encouraged by the early positive response to our EPIC Stent in Europe, where it was launched last month, and we are pleased to begin the process of evaluating it for use in the United States," said Donald S. Baim, M.D., Chief Medical and Scientific Officer of Boston Scientific. "The EPIC Stent is designed to offer a more balanced stent platform, allowing for excellent radial force without compromising stent flexibility and providing physicians a new option for treating iliac disease."

The EPIC Stent is a self-expanding nitinol stent designed to sustain vessel patency (openness), while providing enhanced visibility during placement. The ORION trial incorporates stent diameter ranges from 6-12 mm and lengths up to 120 mm. All stent sizes are compatible with 6F (2.1 mm) sheaths, and the stent delivery system is compatible with 0.035'' (0.89 mm) guidewires.

The trial will enroll 123 patients at
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
2. Boston Scientific Data Show Real-World Survival Rates for Implantable Cardiac Device Patients Exceed Rates From Clinical Trials
3. Journal of American College of Cardiology Article Reports Fewer Repeat Procedures With Boston Scientifics TAXUS(R) Liberte(R) Stent
4. Boston Scientific Welcomes Publication of HORIZONS AMI Trial Results in New England Journal of Medicine
5. Clinical Data Reinforce Safety and Efficacy of Boston Scientifics Two Drug- Eluting Stent Platforms
6. New England Journal of Medicine Publishes Results from Boston Scientifics Landmark SYNTAX(TM) Trial
7. Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents
8. Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
9. Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientifics Next-Generation Taxus Liberte Stent
10. Boston Scientific to Release Broad Range of Clinical Trial Data on the Performance of TAXUS(R) Coronary Stent Systems at TCT 2008
11. Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ANGELES , FARUM, Denmark and ... On July 31, 2015 the US Food and ... the treatment of Major Depressive Disorder in adult patients who ... in the current episode. TMS is a non-invasive technique for ... in patients suffering from Major Depressive Disorder. The procedure has ...
(Date:8/28/2015)... ANDOVER, Massachusetts and LONDON , ... driven approach seamlessly ... health continuum improving outcomes and ... Philips  (NYSE: PHG AEX: PHIA) today announced its presence ... its latest cardiology solutions, including Heart Model A.I. , EchoNavigator ...
(Date:8/27/2015)... -- Biosimilars are not generics and the Biologics ... Drug Administration (FDA) for recognizing that each biosimilar ... issued today. The FDA,s draft guidance on nonproprietary ... for biological products to bear a nonproprietary name ... the agency,s thinking that "there is a need ...
Breaking Medicine Technology:Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 2Therapy System for Treating Major Depressive Disorder Receives FDA Clearance 3Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 2Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 3Philips Showcases New Integrated Cardiology Solutions to Advance Minimally Invasive Procedures at ESC Congress 2015 4Biologics Prescribers Collaborative (BPC) Statement on FDA Draft Guidance entitled "Nonproprietary Naming of Biological Products" 2
... 15, 2012  Fluke Biomedical announced today the newest ... quality-assurance testing and troubleshooting tools, the SPOT ... 15-second preventive maintenance (PM) test for SpO2 patient ... the fastest SpO2 functional tester ever achieved by ...
... Arena Pharmaceuticals, Inc. (NASDAQ: ARNA ) today announced ... other conditions, shares of its common stock in an underwritten public ... the offering may be completed, or as to the actual size ... and Piper Jaffray & Co. are acting as joint book-running managers ...
Cached Medicine Technology:Fluke Biomedical launches speedy new ProSim™ SPOT Light SpO2 Functional Tester 2Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock 2Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock 3Arena Pharmaceuticals Announces Proposed Public Offering of Common Stock 4
(Date:8/28/2015)... ... 2015 , ... Northridge dentists Dr. Elyson and Dr. Assili are ... can currently receive a one hour treatment of this teeth whitening option. Zoom ... number of unique features that can turn teeth up to nine shades whiter. Effective ...
(Date:8/28/2015)... ... August 28, 2015 , ... Healthpointe clinics throughout ... go deep sea diving. The act of recreational diving exposes the body ... reasons, it is vital that all recreational and professional divers undergo regular comprehensive ...
(Date:8/28/2015)... ... August 28, 2015 , ... ... Database have added comprehensive information on two new duals programs: Rhode Island ... 2015 launch; and Idaho’s partnership to revamp Blue Cross of Idaho’s D-SNP. ...
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... External Counterpulsation, ... Heart Fit Clinic is now selling External Counterpulsation (EECP or ECP) machines with a ... Fit Clinic has been in business since 2007 helping people prevent and reverse ...
(Date:8/28/2015)... ... August 28, 2015 , ... A complimentary webinar offered ... Medicare & Medicaid Services’ (CMS) proposal to mandate bundled payments through the ... “Get Ready for Game Day: Comprehensive Care for Joint Replacement,” takes place at 12 ...
Breaking Medicine News(10 mins):Health News:Northridge Dentists Dr. Elyson and Dr. Assili Now Offer a Special Promotion on Zoom Teeth Whitening 2Health News:Healthpointe Now Offering Scuba Physicals 2Health News:AIS Duals Database: August Update Finds Two New Duals Programs in Rhode Island and Idaho 2Health News:Buy New External Counterpulsation (EECP or ECP) With Heart Fit Clinic 2Health News:PYA Offers Complimentary CCJR Webina — Game On 2Health News:PYA Offers Complimentary CCJR Webina — Game On 3
... manufacturer, Compellis Pharmaceuticals, has been granted the PATENT ... //entitled "Inhibition of olfactory neurosensory function to treat ... biopharmaceutical company focusing more on developing novel mechanism-based ... company describes CP404 as "therapeutic platform for treating ...
... common form of brewer's yeast, University of Wisconsin-Madison researchers ... allow it to act as a master regulatory switch ... when malfunctioning in humans, may contribute to serious neurological ... issue of the journal Molecular Cell, shows how a ...
... years old- are as capable as teen-agers in handling ... them as it is more comfortable during activities like ... contact lenses to children until they are at least ... of optometry at Ohio State University. “But we found ...
... cultural or linguistic isolation, young Hispanic women and elderly ... attempting or committing suicide, mental health experts have warned. ... cultural and linguistic isolation, the stress of immigration and ... advocates who attended a hearing in Lower Manhattan on ...
... commissioned a specialty outpatient clinic for patients// with liver-related ... ,This Clinic, besides providing advanced therapeutic options to ... will also focus on preventive measures - said S. ... provision for conducting research in hepatology too – he ...
... President, Dr Choong-Siew Yong, today said the AMA’s ... program has been boosted by the findings of ... Prevention Project. ,The report, released today, demonstrated ... reduced difficult behaviour, and strengthened family relationships. ...
Cached Medicine News:Health News:From a Lowly Yeast, Researchers Divine a Clue to Human Disease 2Health News:Contact Lenses For Younger Children Also 2Health News:Contact Lenses For Younger Children Also 3
... 50 Urine Chemistry Analyzer is designed for use ... time for technicians, allowing them to be more ... It has a throughput of 50 strips per ... results, which may be downloaded to a computer ...
... collection under vacuum process makes the ... reduction. ,The Optivac® Vacuum Mixing ... of continuous improvement since its original ... a consistently high-quality, homogenous cement, with ...
... 35 years, Palacos® Bone Cement has ... standard in cemented arthroplasty. Palacos® is ... gentamicin, providing an antibiotic loaded bone ... second stage of a two-stage revision ...
Occu-Flo Plugs Offer: , Easy Insertion , A polished, smooth, transparent finish which creates immediate patient comfort and adaptation , High tolerance by patients , No discomfort should removal be ...
Medicine Products: